File Download
  Patent History
  • Application
    KR 20087022710 2008-09-17
  • Publication
    KR 20080108465 2008-12-15
  Patent Family
Supplementary

published patent: PROPHYLACTIC OR THERAPEUTIC AGENT FOR CEREBRAL ISCHEMIA OR CEREBRAL ISCHEMIC REPERFUSION INJURY IN STROKE

TitlePROPHYLACTIC OR THERAPEUTIC AGENT FOR CEREBRAL ISCHEMIA OR CEREBRAL ISCHEMIC REPERFUSION INJURY IN STROKE
Priority Date2006-02-20 JP20060041761
Inventors
Chung, SKChung, StephenHibi, Chihiro
Issue Date2008
Citation
Korea Published Patent Application KR 20080108465. Korea: Korean Intellectual Property Office (KIPO), 2008 How to Cite?
AbstractDisclosed is a prophylactic or therapeutic agent for cerebral ischemia injury or cerebral ischemic reperfusion injury occurring in stroke such as cerebral infarction or cerebral hemorrhage, which develops its efficacy through a mechanism different from those of conventional ones and can be administered over a long period. The prophylactic or therapeutic agent comprises 6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide as an active ingredient. Particularly preferably, the compound is fidarestat, which is an optically resolved form having a (2S,4S) configuration. TM KIPO & WIPO 2009
Persistent Identifierhttp://hdl.handle.net/10722/176794

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:29Z-
dc.date.available2012-11-30T08:38:29Z-
dc.date.issued2008-
dc.identifier.citationKorea Published Patent Application KR 20080108465. Korea: Korean Intellectual Property Office (KIPO), 2008en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176794-
dc.description.abstractDisclosed is a prophylactic or therapeutic agent for cerebral ischemia injury or cerebral ischemic reperfusion injury occurring in stroke such as cerebral infarction or cerebral hemorrhage, which develops its efficacy through a mechanism different from those of conventional ones and can be administered over a long period. The prophylactic or therapeutic agent comprises 6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide as an active ingredient. Particularly preferably, the compound is fidarestat, which is an optically resolved form having a (2S,4S) configuration. TM KIPO & WIPO 2009en_HK
dc.titlePROPHYLACTIC OR THERAPEUTIC AGENT FOR CEREBRAL ISCHEMIA OR CEREBRAL ISCHEMIC REPERFUSION INJURY IN STROKEen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorChung, SKen_HK
dc.contributor.inventorChung, Stephenen_HK
dc.contributor.inventorHibi, Chihiroen_HK
patents.identifier.applicationKR 20087022710en_HK
patents.description.assigneeSANWA KAGAKU KENKYUSHO CO [JP]en_HK
patents.description.countryKorea (South)en_HK
patents.date.publication2008-12-15en_HK
patents.date.application2008-09-17en_HK
patents.date.priority2006-02-20 JP20060041761en_HK
patents.description.ccKRen_HK
patents.identifier.publicationKR 20080108465en_HK
patents.relation.familyAU 2007218709 (A1) 2007-08-30en_HK
patents.relation.familyCA 2642933 (A1) 2007-08-30en_HK
patents.relation.familyCN 101389332 (A) 2009-03-18en_HK
patents.relation.familyEP 1987829 (A1) 2008-11-05en_HK
patents.relation.familyKR 20080108465 (A) 2008-12-15en_HK
patents.relation.familyUS 2009076105 (A1) 2009-03-19en_HK
patents.relation.familyWO 2007097301 (A1) 2007-08-30en_HK
patents.description.kindAen_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats